Quince Therapeutics Balance Sheet Health
Financial Health criteria checks 4/6
Quince Therapeutics has a total shareholder equity of $44.9M and total debt of $14.9M, which brings its debt-to-equity ratio to 33.2%. Its total assets and total liabilities are $126.5M and $81.6M respectively.
Key information
33.2%
Debt to equity ratio
US$14.90m
Debt
| Interest coverage ratio | n/a |
| Cash | US$47.85m |
| Equity | US$44.93m |
| Total liabilities | US$81.59m |
| Total assets | US$126.52m |
Recent financial health updates
Here's Why We're Watching Quince Therapeutics' (NASDAQ:QNCX) Cash Burn Situation
Nov 21
We're Keeping An Eye On Cortexyme's (NASDAQ:CRTX) Cash Burn Rate
Dec 15We Think Cortexyme (NASDAQ:CRTX) Can Afford To Drive Business Growth
Aug 23Recent updates
Quince Therapeutics: High-Potential Turnaround With Phase 3 Asset EryDex
Aug 20Here's Why We're Watching Quince Therapeutics' (NASDAQ:QNCX) Cash Burn Situation
Nov 21Cortexyme to change name and ticker symbol next month
Jul 27Cortexyme: A Biotech Worth A Look Based On Potential Alzheimer's Treatment
Mar 01Cortexyme: Drug Candidate COR588 May Offer Some Hope To Investors
Dec 15We're Keeping An Eye On Cortexyme's (NASDAQ:CRTX) Cash Burn Rate
Dec 15Cortexyme: A Challenging Path Forward
Nov 17Cortexyme: Positive Lessons To Be Learned From Disappointing Results
Nov 01Cortexyme And The Gingipain Hypothesis Of Alzheimer's Disease
Oct 11Cortexyme: Alzheimer's Readout In November A Binary Event
Sep 12We Think Cortexyme (NASDAQ:CRTX) Can Afford To Drive Business Growth
Aug 23Cortexyme EPS beats by $0.02
May 10We're Not Very Worried About Cortexyme's (NASDAQ:CRTX) Cash Burn Rate
May 10Insider Buying: The Cortexyme, Inc. (NASDAQ:CRTX) Independent Director Just Bought 2.4% More Shares
Mar 10Financial Position Analysis
Short Term Liabilities: QNCX's short term assets ($51.7M) exceed its short term liabilities ($5.4M).
Long Term Liabilities: QNCX's short term assets ($51.7M) do not cover its long term liabilities ($76.2M).
Debt to Equity History and Analysis
Debt Level: QNCX has more cash than its total debt.
Reducing Debt: QNCX's debt to equity ratio has increased from 0% to 33.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: QNCX has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: QNCX has sufficient cash runway for 1.2 years if free cash flow continues to reduce at historical rates of 0.3% each year.